(Q38994709)

8 September 2017

title

Prognostic value of bcl-2 expression among women with breast cancer in Libya (English)

1 reference

8 September 2017

0 references

Eramah Ermiah

1

1 reference

8 September 2017

Abdelbaset Buhmeida

2

1 reference

8 September 2017

Ben Romdhane Khaled

3

1 reference

8 September 2017

Fathi Abdalla

4

1 reference

8 September 2017

Nada Salem

5

1 reference

8 September 2017

Seppo Pyrhönen

6

1 reference

8 September 2017

Yrjö Collan

7

1 reference

8 September 2017

publication date

16 February 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

34

1 reference

8 September 2017

issue

3

1 reference

8 September 2017

page(s)

1569-1578

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-013-0687-1

8 September 2017

exact match

0 references

cites work

Cancer incidence in eastern Libya: the first report from the Benghazi Cancer Registry, 2003.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Modification and implementation of NCCN guidelines on breast cancer in the Middle East and North Africa region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Patient-mediated factors predicting early- and late-stage presentation of breast cancer in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Apoptosis in mammary gland and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Prognostic significance of apoptosis regulators in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

The Bcl-2 protein family: arbiters of cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

What clinicians need to know about antioestrogen resistance in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Clinical relevance of apoptotic markers in breast cancer not yet clear

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Clinical studies of Bcl-2 and treatment benefit in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Expression of Bcl-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

BCL2 family in DNA damage and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

A multimarker model to predict outcome in tamoxifen-treated breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Apoptosis inhibitor as a suppressor of tumor progression: expression of Bcl-2 eliminates selective advantages for p53-deficient cells in the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Re: Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17 beta-estradiol and the two faces of Janus: sex steroids as mediators of both cell proliferation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Prognostic significance of DNA image cytometry in Libyan breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Breast cancer genetics in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-0687-1

p53 and bcl-2 expression correlates with clinical outcome in a series of node-positive breast cancer patients

21 January 2018

1 reference

12 December 2020

The Nottingham prognostic index in primary breast cancer

1 reference

12 December 2020

Bcl-2 Is a Prognostic Marker in Breast Cancer Independently of the Nottingham Prognostic Index

1 reference

12 December 2020

Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)

1 reference

12 December 2020

BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy

1 reference

12 December 2020

Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy

1 reference

12 December 2020

Breast cancer patients in Libya: Comparison with European and central African patients

1 reference

12 December 2020

p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients

1 reference

12 December 2020

Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells

1 reference

12 December 2020

Expression patterns and prognostic value of Bag-1 and Bcl-2 in breast cancer

1 reference

12 December 2020

Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins

1 reference

12 December 2020

Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.

1 reference

12 December 2020

Primary breast cancer in elderly women: biological profile and relation with clinical outcome

1 reference

12 December 2020

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

12 December 2020

Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes

1 reference

12 December 2020

Immunocytochemical localization of BCL-2 protein in human breast cancers and its relationship to a series of prognostic markers and response to endocrine therapy

1 reference

12 December 2020

Bcl-2 immunostaining: a way to finding unresponsive postmenopausal N+ breast cancer patients.

1 reference

12 December 2020

Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.

1 reference

12 December 2020

Reduced expression of both Bax and Bcl-2 is independently associated with lymph node metastasis in human breast carcinomas

1 reference

12 December 2020

c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients

1 reference

12 December 2020

Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis

1 reference

12 December 2020

10.1007/S13277-013-0687-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1036382921

0 references

1 reference